XML 379 R86.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-based compensation and stockholders' equity - Stock-based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense $ 18.0 $ 23.1 $ 45.1
Cost of Sales | Cost of Commercial Product sales      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 0.0 0.1 0.8
Cost of Sales | Cost of MCM Product sales      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 1.8 3.8 6.5
Cost of Sales | Cost of Bioservices      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 0.2 1.0 1.8
R&D      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 1.1 2.0 5.4
Selling, general and administrative      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense $ 14.9 $ 16.2 $ 30.6